ライフサイエンスコーパス: molecular marker

1 that each cluster corresponds to a different molecular marker.

2 the performance of DeltaNP63alpha, a common molecular marker.

3 rmones and could be clarified using NR1 as a molecular marker.

4 risk of contamination using host-associated molecular markers.

5 d for mating type and a range of polymorphic molecular markers.

6 ipants were Illumina deep-sequenced for five molecular markers.

7 ls based on approval votes received by known molecular markers.

8 ell types of diverse origins, functions, and molecular markers.

9 other option is to predict heading date from molecular markers.

10 ne each mode and identify its phenotypic and molecular markers.

11 ased solely on histology, with an absence of molecular markers.

12 d gene expression, respectively, of relevant molecular markers.

13 f their projection target and discover their molecular markers.

14 eural pathways has suffered due to a lack of molecular markers.

15 he clinical and therapeutic utility of these molecular markers.

16 espective applications as pharmaceuticals or molecular markers.

17 ly classified using location, morphology and molecular markers.

18 ts prognostic role is independent from other molecular markers.

19 s system via lineage-specific GAL4 lines and molecular markers.

20 clinical stratification of patients based on molecular markers.

21 ult of reclassification of common cancers by molecular markers.

22 rphology, but did not drive expression of MG molecular markers.

23 selection-driven outliers on next-generation molecular markers.

24 nsitization, but also the increases in these molecular markers.

25 nd the intratumoral distribution of specific molecular markers.

26 ic Units (OTUs) in those samples using three molecular markers.

27 frequently been encountered among different molecular markers.

28 med from stochastic transfer of hypothetical molecular markers.

29 iple-negative (tumors lacking all 3 standard molecular markers; 15%).

30 ive analyses of progression-free survival by molecular markers (1p/19q co-deletion, MGMT promoter met

31 Molecular markers adjusted for volatility and reactivity

32 ugs is often not predictable on the basis of molecular markers alone.

33 Preoperative risk stratification using molecular markers also may be used to better define the

34 ation of clones was investigated using three molecular markers, ama1-D2, ama1-D3, and cpmp.

35 thylation was strongly associated with other molecular markers and added prognostic information in as

36 ation, giving a new map with a total of 2041 molecular markers and an average marker density which in

37 rchy of this process, it remains unclear how molecular markers and cell states are conserved or have

38 Clinical scores, molecular markers and cellular phenotypes have been used

39 his context, due to the breadth of available molecular markers and correlative experimental patternin

40 ditionally, icSARS-CoV-2 retained engineered molecular markers and did not acquire other mutations.

41 ncubation was assessed in mouse slices using molecular markers and electrophysiological recording.

42 Three delimitation approaches (morphology, molecular markers and geography) were applied providing

43 Studies now aim to identify molecular markers and imaging techniques that can detect

44 ostic entities as well as a lack of specific molecular markers and limited understanding of disease p

45 bolomics methods have already identified new molecular markers and metabolomic signatures of cardiova

46 cs and determination of risk parameters, (2) molecular markers and minimal residual disease detection

47 A diagnostic algorithm consisting of two molecular markers and one consensus histologic feature w

48 (592 fasting serum metabolites) to identify molecular markers and pathways associated with serum ele

49 that are indistinguishable using traditional molecular markers and that draw substantial conservation

50 x) to simultaneously interrogate morphology, molecular markers, and connectivity in the same brain se

51 leotide Polymorphisms (SNPs) are widely used molecular markers, and their use has increased massively

52 ing genes; can be accurately predicted using molecular markers; and can enhance or decrease consumers

53 of polymorphic, informative, and functional molecular markers are essential for studying a wide rang

54 Molecular markers are not used in diagnosis or determina

55 up to three generations before conventional molecular markers are observable.

56 e genes to serve as diagnostic or prognostic molecular markers are unknown.

57 potential to increase genetic gains by using molecular markers as predictors of breeding values of in

58 trend in the development and application of molecular marker assays for gene mapping and discovery i

59 genic traits in perennial species can inform molecular marker-assisted breeding.

60 This information may be used in molecular marker-assisted selection of cattle breeding i

61 lex DNA devices able to sense and respond to molecular markers associated with abnormal metabolism.

62 uencing was used to assess the prevalence of molecular markers associated with artemisinin resistance

63 ral vascularization and proper expression of molecular markers associated with BBB formation.

64 e transcriptome sequencing to identify novel molecular markers associated with BP response to TD.

65 mice exhibited an increase in expression of molecular markers associated with dyskinesias.

66 viruses infecting humans to rapidly acquire molecular markers associated with mammalian adaptation a

67 ting the need to investigate novel potential molecular markers associated with mortality.

68 Molecular markers associated with resistance to SMC drug

69 There is a need to discover molecular markers associated with these traits in order

70 ng previously-undefined cell populations and molecular markers at an unprecedented pace.

71 We evaluated the impact of molecular markers at baseline and during follow-up in 38

72 encing metastatic tumour genomes to identify molecular markers at this lethal stage of disease.

73 f 532 cancers in 519 women, all of which had molecular markers available, were included in the analys

74 t cancer tissues entailed active research on molecular marker-based early diagnosis of metastasis.

75 ook on type II hair cell properties based on molecular markers, basolateral conductances and synaptic

76 uate (14)C records for two complementary PyC molecular markers, benzene polycarboxylic acids (BPCAs)

77 nd distinct differences in the colabeling of molecular markers between the parasubiculum and the MEC,

78 gy of these conditions by defining objective molecular markers but also aid in margin assessment to i

79 inin resistance can be tracked using the K13 molecular marker, but no marker exists for piperaquine r

80 ssociated changes in cardiac performance and molecular markers, but do not have findings consistent w

81 (1100-1200 CE), successfully detecting three molecular markers, caffeine, theobromine, and theophylli

82 Molecular markers can allow subtypes of tumors of the sa

83 Additionally, cell types defined by specific molecular markers can exhibit distinct, context-dependen

84 ions in flow cytometry that are not based on molecular markers captured in PRO, but on forward- and s

85 Histopathologic damage and molecular markers (caspase-3 activity and heme oxygenase

86 els were associated with enhanced senescence molecular markers, chlorophyll degradation, and earlier

87 or immunostaining, demonstrated that the 12 molecular markers collectively define 10 different sSC n

88 The approach-informed by regional molecular markers, concurrent Alzheimer's pathology anal

89 Molecular markers conferring resistance to fluoroquinolo

90 Double labeling with other molecular markers confirmed that the labeled SGNs were n

91 It may model and analyse molecular marker data with or without allele dosage info

92 peats were identified, which will facilitate molecular marker development.

93 ication of U MN identity, and that embryonic molecular markers do not accurately predict U MN termina

94 Molecular markers downstream of gemcitabine treatment in

95 Using K13 mutations as molecular markers, epidemiological studies are now track

96 No molecular markers exist that can predict the toxicity of

97 ons, putative excitatory/inhibitory outputs, molecular marker expression, and biophysical properties.

98 ction neurons are highly diverse in terms of molecular marker expression, synaptic targeting (identit

99 ical properties, morphological features, and molecular marker expression.

100 A common molecular marker for all osteogenic mesenchymal progenit

101 Pru du 6 is a potential new molecular marker for almond allergy.

102 asma membrane with CAV1 and Cavin-1, another molecular marker for caveolae in both cell phenotypes.

103 We quantified relative telomere length, a molecular marker for cellular age, and compared lengths

104 ps to the SfABCC2 gene and provides a useful molecular marker for detecting the SfABCC2mut allele in

105 B member 5 (ABCB5) has been identified as a molecular marker for distinct subsets of chemoresistant

106 d gene (dnd) homolog (tdnd) and used it as a molecular marker for germ cells to obtain basic informat

107 model, we demonstrate that m(6)A serves as a molecular marker for innate immune discrimination of sel

108 mplicate IRX1 hypomethylation as a potential molecular marker for lung metastasis, and suggest that e

109 via levels of phosphorylation (P-S6k), is a molecular marker for sedation and overall neuronal activ

110 at Gata3 expression might provide a reliable molecular marker for the identification of elusive proge

111 rtial FLAG epitope may itself be useful as a molecular marker for the rapid screening of citrus plant

112 or set of traits is essential for developing molecular markers for alfalfa breeding.

113 rpretation of in vitro sensitivity tests and molecular markers for artemisinin resistance and for con

114 obtain urinary cytology or other urine-based molecular markers for bladder cancer detection in the in

115 nt, we found a striking decrease in multiple molecular markers for CA2, an effect mimicked by chronic

116 nd MYH7, respectively, which are established molecular markers for cardiac remodeling.

117 nt to which visible indicators correspond to molecular markers for cardiovascular stress is unknown f

118 This study demonstrates the utility of molecular markers for discerning OA pollution sources in

119 nity for machine learning models to identify molecular markers for disease diagnosis and progression.

120 C), the hub of the central auditory pathway, molecular markers for distinct classes of inhibitory neu

121 identified proprioceptors, this work reveals molecular markers for distinct proprioceptor subsets, in

122 scriptomes, we identified 19 cell types with molecular markers for each and used histological methods

123 We identified molecular markers for each type and used them to charact

124 need for developing comprehensive panels of molecular markers for early disease detection and precis

125 subtypes based on the presence or absence of molecular markers for estrogen or progesterone receptors

126 uality, including identification of possible molecular markers for flavor characterizing.

127 Our results also identify new molecular markers for HSV-1 infection and new targets fo

128 ial to provide novel therapeutic targets and molecular markers for improved clinical management of pa

129 oteins such as parvalbumin and calbindin are molecular markers for interneuron subtypes, and are co-e

130 s in physiological parameters were observed, molecular markers for iron starvation, such as Iron Star

131 ly understood leading to a lack of effective molecular markers for its diagnosis.

132 otide polymorphisms (SNPs) are the benchmark molecular markers for modern genomics.

133 inflammation and lung function and identify molecular markers for neutrophilic asthma.

134 ous, identification of clinically meaningful molecular markers for outcome prediction is challenging.

135 silviculture, only a very limited number of molecular markers for pathogen resistance have been vali

136 We aimed to identify molecular markers for predicting prognosis and conversio

137 rtemisinin-resistant parasites may yield new molecular markers for resistance surveillance, which may

138 s have the potential to be used as candidate molecular markers for resistance to myrtle rust.

139 Neural circuit analysis relies on having molecular markers for specific cell types.

140 descent infection by parasites with the same molecular markers from days 8 to 42 (defined as cure).

141 We investigated potential molecular markers from three ASD-associated physiologica

142 ucted to explore the enset genome to develop molecular markers, genomics resources, and characterize

143 T: The identification of cell-type-selective molecular markers has fostered tremendous insight into h

144 The identification of cell-type-selective molecular markers has fostered tremendous insight into h

145 ades, several novel biological, genetic, and molecular markers have been shown to be useful adjuncts

146 Universal molecular markers have been used to identify these speci

147 Molecular markers have been used to study parasite trans

148 However, molecular markers have failed to reveal subtle biogeogra

149 oach, as the identities of cell-specific PSC molecular markers have remained elusive.

150 ues, transgenic lines and well-characterized molecular markers, have made histological assessment of

151 Due to selection of different molecular markers, however, integrating all the datasets

152 by axons from the lateral habenula, and some molecular markers identified as specifically expressed i

153 We show that unique molecular markers identify vagal neurons with distinct i

154 ty in abundance and Delta(14)C values of DBC molecular markers imply dynamic sources and cycling in a

155 A) receptor densities can identify objective molecular markers in ASD.

156 n animal model had early effects on specific molecular markers in circulating peripheral blood mononu

157 probably use blood-specific or lung-specific molecular markers in combination with other clinical, ph

158 the rapid and reliable detection of multiple molecular markers in complex samples.

159 They are robust molecular markers in many areas of studies.

160 DNA is one of the most extensively sequenced molecular markers in plant systematics.

161 e first analyzed the mRNA levels of selected molecular markers in response to sulforaphane ex vivo tr

162 This approach led to the identification of molecular markers in Solanum lycopersicum L. and Cucurbi

163 analgesic nalbuphine in reducing LID and its molecular markers in the nonhuman primate model.

164 in mouse cortical layer V; express distinct molecular markers, including Norrin and leucine-rich rep

165 roperties, and comprehensively validated new molecular markers, including Nppb, encoding B-type natri

166 al T excess increased the gene expression of molecular markers involved in insulin signaling and thos

167 Genetic analysis of molecular markers is critical in tracking the emergence

168 ) Walp (cowpea) accessions using informative molecular markers is imperative for their genetic improv

169 Molecular markers linked to spotted wilt resistance coul

170 Further validation of the identified molecular markers may enable the future stratification o

171 liculus and suggest that these extracellular molecular markers may provide a key to distinguishing in

172 Molecular markers might improve risk stratification of c

173 Doing so is feasible because with molecular markers, mixed-model approaches that require m

174 n neurons displaying a correct expression of molecular markers, morphology and electrophysiological a

175 No correlation between any of the analyzed molecular marker (mutations or amplifications) (TP53, HE

176 ved cell-free DNA (dd-cfDNA) is an important molecular marker of active graft injury.

177 Telomere length is a molecular marker of biological aging.

178 whether perylene serves as a source-specific molecular marker of fungal activity in forest soils.

179 ngs identify increased amounts of mtDNA as a molecular marker of MD and have important implications f

180 l-expressing neural glial antigen 2, a known molecular marker of pericytes in multiple organs.

181 fied neuron-glia antigen 2 (NG2) as a unique molecular marker of S100beta+ PSCs in skeletal muscle.

182 demonstrate that human DNA levels, a stable molecular marker of sampling quality, were significantly

183 a rodent model, our study identifies a novel molecular marker of susceptibility to stress-induced anh

184 N, emphasizing its utility as a new specific molecular marker of the human SAN and as a potential tar

185 red treatment options, and identification of molecular markers of aggressiveness could provide valuab

186 ge predicts survival [1] and associates with molecular markers of aging such as telomere length [2].

187 cal alveolar epithelial cells in IPF express molecular markers of airway epithelium.

188 allmark of traumatic brain injury (TBI) with molecular markers of angiogenesis and endothelial functi

189 anscriptome-wide sequencing data to identify molecular markers of antihypertensive drug response.

190 us TRACI trial in 2011-13, the prevalence of molecular markers of artemisinin resistance (kelch13 Cys

191 , multiantigen sequence types (NG-MAST), and molecular markers of azithromycin resistance.

192 e multiantigen sequence types (NG-MAST), and molecular markers of azithromycin resistance.

193 for simultaneous measurement of cellular and molecular markers of cancer.

194 n of PLN protein and increases expression of molecular markers of cardiac hypertrophy in iPSC-CMs.

195 yslipidemia, markers of oxidative stress and molecular markers of disease activity and fibrosis.

196 ence of parasitaemia and anaemia, to monitor molecular markers of drug resistance, and to measure ins

197 required for high-throughput surveillance of molecular markers of drug resistance.

198 gical evidence of insulin-producing cells or molecular markers of endocrine tissue in BM biopsy sampl

199 ain excitability by deleting MapT suppressed molecular markers of epileptogenesis and seizures.

200 Molecular markers of epithelial plasticity and fibrosis

201 on for screening the key functional genes or molecular markers of estrus expression in gilts.

202 t of NF-kappaB and inducing the synthesis of molecular markers of ET.

203 tochemical studies (Masson trichrome stain), molecular markers of fibrosis (collagen and transforming

204 and matrix metallopeptidases; identifies new molecular markers of infection; and provides potential n

205 behavior, glucose homeostasis, endocrine and molecular markers of insulin resistance, and organ weigh

206 Molecular markers of insulin signaling and cardiac hyper

207 testing, questionnaires, and physical data (Molecular Markers of Melanoma Study data set) including

208 Metabolic and molecular markers of muscle metabolism were measured in

209 Therefore, it is essential to identify the molecular markers of NAI resistance among specific NA su

210 ovascular structure and function, as well as molecular markers of profibrosis.

211 d to identify stress responsive genes as new molecular markers of quality that can be widely applied

212 ia patients is impractical, researchers need molecular markers of resistance that can be more readily

213 licated P. falciparum malaria in relation to molecular markers of resistance.

214 -associated morphology and reduced levels of molecular markers of senescence p16(INK4a) , p53, p21 an

215 Molecular markers of sorafenib efficacy in patients with

216 he ciliary membrane, and are correlated with molecular markers of subcompartments, including the lume

217 The frequency of molecular markers of sulfadoxine-pyrimethamine (SP) and

218 IPTp dose, and for studies that reported on molecular markers of sulfadoxine-pyrimethamine resistanc

219 In this study, we analyzed various molecular markers of T and B cell numbers in neonatal dr

220 ivity of age-related diseases and highlights molecular markers of the aging process that might drive

221 GLO1 inhibitor (pBBG), but not FLX, induced molecular markers of the antidepressant response includi

222 Using in vivo phage display, we searched for molecular markers of the neurovascular unit, including e

223 AKI exist, each with distinct patterning of molecular markers of tubular injury and SCr data.

224 the development of robust and tightly linked molecular markers on LG10 through chromosome walking app

225 ng the current or recent effective size from molecular marker or sequence data.

226 However, the best molecular marker or test to use has not yet been identif

227 To date there are no distinctive molecular markers or detailed morphologies available for

228 temisia, which are difficult to define using molecular markers or morphology.

229 Molecular markers potentially can augment the diagnostic

230 133 patients to determine whether candidate molecular markers predicted parasite recrudescence follo

231 on with gas chromatography mass spectrometry molecular markers quantification, underlined the predomi

232 m 57 carbohydrate microarrays and identified molecular markers reflecting a diversity of specific xyl

233 Molecular markers selectively expressed in the vasculatu

234 mong even the epithelial cells, where unique molecular markers separated presumptive bud and duct cel

235 We mapped the molecular markers sequences from this study and several

236 Fasting skeletal muscle molecular markers showed increased myostatin expression,

237 we show that machine learning can determine molecular marker status, as assessed by hormone receptor

238 tissue morphology and the expression of the molecular markers studied.

239 Molecular marker studies and pathologic analyses from su

240 rs tumor expansion dynamics independently of molecular markers such as putative cancer stem cell (CSC

241 ly variable regions and potential sources of molecular markers such as simple sequence repeats, large

242 tes immunopositive for interneuron cell-type molecular markers, such as parvalbumin, calbindin, calre

243 Given a set of biallelic molecular markers, such as SNPs, with genotype values en

244 Rigorous digitally measured histologic and molecular markers suitable for gluten challenge studies

245 ces of fecal contamination in waterways, use molecular markers targeting host-associated bacteria in

246 Molecular marker testing may be helpful in guiding patie

247 The 2 most studied molecular marker testing techniques for indeterminate th

248 Molecular marker tests such as ThyroSeq version 2.1 are

249 ne H3-like protein Cse4/CENP-A acts as a key molecular marker that differentiates the special centrom

250 BR28, which binds to translocator protein, a molecular marker that is up-regulated by microglial acti

251 Therefore, we propose another useful molecular marker that may be employed for future epidemi

252 e contributions calculated with the modified molecular markers that account for volatility and reacti

253 Notably, recent H9N2 viruses have acquired molecular markers that allow for a transition from avian

254 We identify molecular markers that are predictive of differentiation

255 Identification of molecular markers that are related to different types of

256 Further, molecular markers that are significantly altered in ecto

257 remains poor, mainly due to lack of reliable molecular markers that can be used for targeted therapy.

258 s, have presented an opportunity to identify molecular markers that can complement existing histology

259 nding of sSC neurons is impeded by a lack of molecular markers that define specific cell types.

260 ics have been applied to discover subsets of molecular markers that identify target classes of clinic

261 MALDI-MSI identified endogenous molecular markers that illustrated the villi structures

262 Molecular markers that predict failure of artemisinin co

263 llustrations, detailed text descriptions and molecular markers that selectively label muscle, nerves/

264 ntre of plant domestication, on the basis of molecular markers that show genetic similarities between

265 In addition, we identified molecular markers that were highly enriched in UCP1-posi

266 xaploid wheat, and we developed a diagnostic molecular marker to accelerate its deployment and pyrami

267 through time and space and may function as a molecular marker to follow any further spread of these v

268 ke protein, which could be further used as a molecular marker to follow viral spread within the count

269 of peripheral blood samples might be a novel molecular marker to help early identification of patient

270 hMATE1 may have applications as a pan-cancer molecular marker to identify and target tumors that are

271 al CNGA3 as a hypothalamic cold sensor and a molecular marker to interrogate the neuronal circuitry u

272 These suggested eEF1A1 as a molecular marker to predict the selectivity and efficien

273 lticopy plasmepsin 2 constitutes a surrogate molecular marker to track piperaquine resistance.

274 d candidate genes will permit development of molecular markers to aid breeding for high NUE.

275 Here we apply molecular markers to analyze its population structure an

276 s, some population assignment techniques use molecular markers to assign individuals to known groups.

277 e leverage new mouse lines, viral tools, and molecular markers to better define GPe neuron subtypes.

278 Here, we use genome-wide molecular markers to characterize the population genetic

279 e-specific proteins provides a robust set of molecular markers to define the human PSC state and allo

280 Molecular markers to detect subtypes of cancer cells cou

281 lyses provide greater power than traditional molecular markers to detect the genetic consequences of

282 To provide powerful molecular markers to explore the population genetic dive

283 ck on tumors, with clinical implications for molecular markers to modify emerging treatments.

284 Use of efficacious molecular markers to obtain the required knowledge of th

285 d/or sst5TMD4 levels, might represent useful molecular markers to predict the ultimate response of pi

286 han previously appreciated in chickens using molecular markers to stain oral epithelial sheets of the

287 We therefore developed new molecular markers to understand patterns of genetic dive

288 t trait and further allow the development of molecular markers to utilise this trait to exploit homoe

289 To date, however, only few of the available molecular markers truly influence clinical decision-maki

290 cer, estrogen receptor status (ERS) is a key molecular marker used for prognosis and treatment decisi

291 NAs-mRNAs networks and to identify potential molecular markers via a computational method.

292 ste buds in oral epithelial sheets using the molecular markers Vimentin and alpha-Gustducin.

293 The use of some of these chemicals as sewage molecular markers was also investigated.

294 Molecular markers were more sensitive than visible toxic

295 ns to PM(0.1) OC calculated with traditional molecular markers were similar to the source contributio

296 These molecular markers were used in a study of genetic divers

297 BRAF V600E and SRC mutations are important molecular markers which can predict prognosis and conver

298 identified hundreds of novel region-specific molecular markers, which may serve as tools to target se

299 Our protocol for labeling taste buds with molecular markers will factilitate future mechanistic st

300 distinct distribution patterns of different molecular markers within the parasubiculum, across both